Criminal Complaint Against Swissmedic
Become a member: Subscribe
NTS Headlines
Headlines by Category
Headlines by Year
Solari’s Building Wealth materials are organized to inspire and support your personal strategic and financial planning.
Building Wealth
This 6-pillar curriculum teaches the basic literacy we need to be personally and financially successful and to do so in a manner in which together we evolve a culture that supports the emergence of an advanced human civilization.
Missing Money
Articles and video discussions of the $21 Trillion dollars missing from the U.S. government
Connect with the wider network of like-minded Solari subscribers using our in-house social media platform, Solari Connect.
No posts
Criminal Complaint Against Swissmedic
Introduction:
1 The subject of the present study is the temporary approvals of the two mRNA- COVID ” vaccines ” from Pfizer/BioNTech (Comirnaty®, market share 37%) and Moderna (Spikevax®, market share 62.6%) 1 that are primarily used in Switzerland.
2 First, the authorisation decisions of Swissmedic are presented in chronological order.
3 Subsequently, the mRNA vaccines are examined for their risks and efficacy. The structure in the corresponding section follows the structure of the main document – but one hierarchy level/title level higher, in order to ha ve an additional title level available for further explanations. Subsequently, the hazardousness of Sars- Cov2 is examined ac- cording to the same pattern
4 Finally, some of the publicity announcements made by Swissmedic are examined for their truthfulness.
Oringinal story can be found here.
Media Conference: Criminal complaint against Swissmedic
View PDF of Kruse-Law complaint
